techJuly 23, 2026·MIT Tech Review
How AI helps scientists design the next generation of medicines
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered pro
Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered proteins rather than synthetic chemistry (which are often used to…
Key Takeaways
- •Designing and developing a new medicine is an expensive, failure-prone scientific challenge
- •This story was reported by MIT Tech Review, covering developments in the tech space.
- •AI advancements continue to reshape industries — read the full article on MIT Tech Review for complete coverage.
📖 Continue reading the full article:
Read Full Article on MIT Tech Review →
![I briefly tried Gemini Intelligence, and I’m still not sure who it’s for [Video]](https://9to5google.com/wp-content/uploads/sites/4/2026/07/Gemini-Intelligence-Task-Automation-on-Galaxy-Z-Fold-8-wide-4.jpg?quality=82&strip=all&w=1600)
